Trial Profile
A Prospective, Randomized, Bi-center Study to Compare the Outcome of Adjuvant Radiotherapy With Concomitant or Sequential Arimidex in Postmenopausal Women With Breast Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics; Registrational
- 24 Jun 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2013 to 1 Jul 2015.
- 21 May 2014 Status changed from recruiting to active, no longer recruiting, according to abstract presented at American Society of Clinical Oncology Meeting.
- 21 May 2014 Results to be presented at the 50th Annual Meeting of the American Society of Clinical Oncology on 3 Jun, 2014.